TACC3 and central nervous system cancer: A comparison between 34 high-grade F3T3 gliomas and 100 GBM IDH-wildtype cases lacking FGF3::TACC3 fusion revealed that the former were more likely to be assigned the mesenchymal or RTK II subclass than the latter [11].